Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery
NCT ID: NCT01173133
Last Updated: 2011-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2009-04-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
NCT03757793
Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device
NCT03715270
Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
NCT00671385
Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging
NCT02273076
Tissue Oxygenation Measurements With Modulated Light (S-FLARE)
NCT01116297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mills-Peninsula Medical Center
UNKNOWN
Stanford University
OTHER
Spectros Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Spectros Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mills Penisula Hospital
Burlingame, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
John Griffin, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
John Griffin, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLA-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.